A recent preprint from Israel has some encouraging news–and some not so encouraging news about long COVID and vaccination. The good news is that two or more doses (there was no attempt to break out two versus three doses) dramatically lowers long COVID symptoms in people who were not hospitalized for COVID, especially in the elderly (table 3):
The not-so-good news is frequency at which symptoms are observed in people with two doses (table 2; not the entire table, but in order of common to less common symptoms; there isn’t much that can be said about the rare symptoms:
For context, we need to remember that some people will develop these symptoms anyway: for example, the six percent of people who have weakness in the arms or legs is likely ‘overattributed’ to COVID. There also might be some sampling issues. Nonetheless, it really does seem that, even in vaccinated people, 0.5% to two percent of people who haven’t been hospitalized wind up with some nasty long-term shit (‘nasty long-term shit’ is a highly technical medical term)–and that is including a conservative ‘fudge factor.’
Hopefully, three doses will provide more protection, and maybe, if we’re lucky, Omicron doesn’t cause as much long COVID. Still seems like something to avoid if you can help it.